Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Mar-24 7:26 PM View:  | An2 Therapeutics, Inc. (ANTX) | 15-Mar-24 | Grant | 99,000 | -- | -- | 8% 1.21M to 1.31M | |
| 04-Jan-24 6:05 PM View: | An2 Therapeutics, Inc. (ANTX) | 02-Jan-24 | Private Sale (Planned) | 2,777 | $20.09 | $55,802.40 | (< 1%) 1.21M to 1.21M | |
| 15-May-23 8:01 PM View: | An2 Therapeutics, Inc. (ANTX) | 15-May-23 | Private Purchase | 10,000 | $5.38 | $53,770.00 | < 1% 1.2M to 1.21M | |
| 14-Nov-22 8:48 PM View: | An2 Therapeutics, Inc. (ANTX) | 14-Nov-22 | Market Sale (Planned) | 23 | $15.04 | $345.92 | (< 1%) 4.93K to 4.91K | < 1% |
| 14-Nov-22 8:48 PM View: | An2 Therapeutics, Inc. (ANTX) | 10-Nov-22 | Market Sale (Planned) | 4,413 | $15.32 | $67,628.30 | (47%) 9.34K to 4.93K | 2% |
| 09-Nov-22 8:33 PM View: | An2 Therapeutics, Inc. (ANTX) | 09-Nov-22 | Market Sale (Planned) | 10,111 | $15.61 | $157,847.00 | (67%) 15.02K to 4.91K | 4% |
| 09-Nov-22 8:33 PM View: | An2 Therapeutics, Inc. (ANTX) | 08-Nov-22 | Market Sale (Planned) | 7,055 | $15.58 | $109,947.00 | (32%) 22.07K to 15.02K | 4% |
| 07-Nov-22 8:19 PM View: | An2 Therapeutics, Inc. (ANTX) | 07-Nov-22 | Market Sale (Planned) | 12,203 | $16.04 | $195,741.00 | (71%) 17.11K to 4.91K | 6% |
| 07-Nov-22 8:19 PM View: | An2 Therapeutics, Inc. (ANTX) | 04-Nov-22 | Market Sale (Planned) | 8,828 | $15.80 | $139,474.00 | (34%) 25.94K to 17.11K | 5% |
| 07-Nov-22 8:19 PM View: | An2 Therapeutics, Inc. (ANTX) | 03-Nov-22 | Market Sale (Planned) | 14,165 | $15.75 | $223,058.00 | (35%) 40.1K to 25.94K | 5% |
| 02-Nov-22 8:52 PM View: | An2 Therapeutics, Inc. (ANTX) | 02-Nov-22 | Market Sale (Planned) | 1,544 | $15.07 | $23,262.50 | (24%) 6.45K to 4.91K | < 1% |
| 02-Nov-22 8:52 PM View: | An2 Therapeutics, Inc. (ANTX) | 31-Oct-22 | Market Sale (Planned) | 2,688 | $15.39 | $41,362.70 | (29%) 9.14K to 6.45K | 2% |
| 28-Oct-22 8:27 PM View: | An2 Therapeutics, Inc. (ANTX) | 28-Oct-22 | Market Sale (Planned) | 1,683 | $15.09 | $25,392.40 | (26%) 6.59K to 4.91K | < 1% |
| 28-Oct-22 8:27 PM View: | An2 Therapeutics, Inc. (ANTX) | 27-Oct-22 | Market Sale (Planned) | 924 | $15.36 | $14,190.00 | (12%) 7.51K to 6.59K | 2% |
| 26-Oct-22 9:19 PM View: | An2 Therapeutics, Inc. (ANTX) | 26-Oct-22 | Market Sale (Planned) | 1,678 | $15.10 | $25,342.00 | (25%) 6.58K to 4.91K | < 1% |
| 26-Oct-22 9:19 PM View: | An2 Therapeutics, Inc. (ANTX) | 25-Oct-22 | Market Sale (Planned) | 4,806 | $15.75 | $75,672.20 | (42%) 11.39K to 6.58K | 5% |
| 26-Oct-22 9:19 PM View: | An2 Therapeutics, Inc. (ANTX) | 24-Oct-22 | Market Sale (Planned) | 2,866 | $16.17 | $46,343.50 | (20%) 14.26K to 11.39K | 7% |
| 24-Oct-22 9:44 PM View: | An2 Therapeutics, Inc. (ANTX) | 21-Oct-22 | Sale (Planned) | 13,951 | $16.36 | $228,240.00 | (74%) 18.86K to 4.91K | |
| 24-Oct-22 9:44 PM View: | An2 Therapeutics, Inc. (ANTX) | 20-Oct-22 | Private Sale (Planned) | 7,293 | $16.68 | $121,672.00 | (28%) 26.15K to 18.86K | |
| 31-Mar-22 8:15 PM View: | An2 Therapeutics, Inc. (ANTX) | 29-Mar-22 | Conversion | 4,907 | -- | -- | 100% 0 to 4.91K |